Recombinant CD3 (Teplizumab Biosimilar) 抗体
Our Local Distributor
北京 101111
Quick Overview for Recombinant CD3 (Teplizumab Biosimilar) 抗体 (ABIN7795117)
抗原
抗体类型
适用
宿主
克隆类型
标记
应用范围
质量等级
-
-
Expression System
- Mammalian cells
-
原理
- Teplizumab Biosimilar, Human CD3e Monoclonal Antibody
-
产品特性
- Teplizumab biosimilar uses the same protein sequences as the therapeutic antibody teplizumab (humanized OKT3). A fully human monoclonal antibody that binds to CD3 epsilon of the T cell receptor-CD3 complex, teplizumab (humanized OKT-3) is used to delay the onset of stage 3 type 1 diabetes (T1D) in people with stage 2 T1D.
-
纯化方法
- Protein A or G affinity column
-
纯度
- >95 % by reducing SDS-PAGE
-
内毒素水平
- < 1 EU per 1 mg of the protein by the LAL method
-
免疫原
- Human CD3e
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- > 3 mg/mL
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.
-
-
- CD3 (Teplizumab Biosimilar)
-
别名
- Teplizumab Biosimilar
-
物质类
- Biosimilar
抗原
-